RODOLICO, Carmelo
 Distribuzione geografica
Continente #
EU - Europa 12.262
NA - Nord America 10.548
AS - Asia 6.812
SA - Sud America 2.364
AF - Africa 187
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 32.190
Nazione #
US - Stati Uniti d'America 10.324
RU - Federazione Russa 6.327
SG - Singapore 2.866
BR - Brasile 2.011
CN - Cina 1.930
IE - Irlanda 1.499
SE - Svezia 1.162
HK - Hong Kong 787
IT - Italia 684
DE - Germania 577
UA - Ucraina 458
FR - Francia 393
VN - Vietnam 370
FI - Finlandia 321
PL - Polonia 314
GB - Regno Unito 234
IN - India 177
AR - Argentina 128
BD - Bangladesh 120
CA - Canada 109
TR - Turchia 95
NL - Olanda 70
BE - Belgio 59
ZA - Sudafrica 58
MX - Messico 56
ID - Indonesia 55
VE - Venezuela 52
EC - Ecuador 51
IQ - Iraq 51
JP - Giappone 44
AT - Austria 43
PK - Pakistan 41
CO - Colombia 40
UZ - Uzbekistan 40
MA - Marocco 29
PY - Paraguay 29
ES - Italia 28
TN - Tunisia 23
MY - Malesia 20
CI - Costa d'Avorio 19
CZ - Repubblica Ceca 19
AZ - Azerbaigian 17
CL - Cile 17
KE - Kenya 17
LT - Lituania 17
PE - Perù 17
IL - Israele 16
JO - Giordania 16
AE - Emirati Arabi Uniti 15
IR - Iran 14
JM - Giamaica 14
KZ - Kazakistan 14
NP - Nepal 14
SA - Arabia Saudita 14
EG - Egitto 12
PH - Filippine 12
UY - Uruguay 11
DO - Repubblica Dominicana 10
LB - Libano 10
OM - Oman 10
TH - Thailandia 10
DZ - Algeria 9
GT - Guatemala 8
KG - Kirghizistan 8
AM - Armenia 7
BO - Bolivia 7
AU - Australia 6
CR - Costa Rica 6
EU - Europa 6
KR - Corea 6
PA - Panama 6
PS - Palestinian Territory 6
CH - Svizzera 5
NI - Nicaragua 5
RO - Romania 5
AL - Albania 4
BY - Bielorussia 4
GR - Grecia 4
KW - Kuwait 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
BN - Brunei Darussalam 2
DK - Danimarca 2
GA - Gabon 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
Totale 32.153
Città #
Moscow 1.911
Ashburn 1.505
Dublin 1.490
Singapore 1.468
Dallas 1.180
Chandler 1.072
Jacksonville 938
Hong Kong 785
Nyköping 710
Beijing 675
San Jose 519
The Dalles 355
Warsaw 299
Princeton 274
Los Angeles 256
Lauterbourg 240
Medford 229
Cambridge 225
Ann Arbor 201
Des Moines 193
Dearborn 174
New York 147
Messina 146
São Paulo 143
Council Bluffs 138
Munich 129
Buffalo 126
Ho Chi Minh City 124
Boardman 109
Tianjin 100
Wilmington 85
Hanoi 76
Guangzhou 75
Shenyang 73
Jinan 72
San Mateo 70
Nanjing 64
Belo Horizonte 63
Frankfurt am Main 63
Orem 60
Turku 60
Rio de Janeiro 58
Redondo Beach 57
Rome 52
Bremen 50
Brooklyn 50
Santa Clara 49
Woodbridge 48
Lancaster 45
Brussels 41
Hyderabad 40
Ningbo 39
Istanbul 38
Tokyo 38
Shanghai 35
Tashkent 35
Hebei 34
Atlanta 33
Houston 33
Pune 33
Seattle 32
Brasília 31
Catania 31
Chennai 31
Helsinki 31
Hangzhou 30
Milan 30
Montreal 29
Haikou 28
Zhengzhou 28
Dong Ket 26
Falls Church 26
San Francisco 26
Stockholm 26
Amsterdam 25
Campinas 25
Nuremberg 25
Porto Alegre 25
Shenzhen 25
Vienna 25
Curitiba 24
Denver 24
Johannesburg 24
Boston 23
Toronto 23
Guayaquil 22
Manchester 21
Mumbai 21
Dhaka 20
Taizhou 20
Abidjan 19
Baghdad 19
Jakarta 19
Ottawa 19
Salvador 19
London 18
Baku 17
Buenos Aires 17
Fortaleza 17
Naples 17
Totale 18.388
Nome #
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 251
Clinical and pathological features of focal myositis 248
Le sindromi miasteniche congenite 230
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 221
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 216
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 211
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 208
A life threatening case of β-enolase deficiency 203
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 199
Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy. 194
Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy 193
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 191
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 190
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 190
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 188
Hippo signaling pathway is altered in Duchenne muscular dystrophy 187
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 178
Central and peripheral autonomic failure in cold induced sweating syndrome type 1 177
Advances in assessing myotonia: Can sensor-engineered glove have a role? 177
ANT1 is reduced in sporadic inclusion body myositis. 177
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 175
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 175
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 173
A standardized clinical evaluation of patients affected by facioscapulohumeralmuscular dystrophy: The FSHD clinical score. 173
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 169
Cardiovascular autonomic control in Becker muscular dystrophy 169
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 168
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 167
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 166
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 166
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 166
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 166
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 166
Apoptosis and apoptosis-related proteins in thyroid myopathies 165
Autoimmune juvenile limb-girdle myasthenia 165
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 164
Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis 163
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 162
Aging-associated genes and let-7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy 160
Italian recommendations for the diagnosis and treatment of myasthenia gravis 158
Toward a more personalized motor function rehabilitation in myotonic dystrophy type 1: The role of neuroplasticity 158
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 157
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 156
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 155
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 155
A 5-year clinical follow-up study from the Italian National Registry for FSHD 155
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 154
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 154
Miotonia congenita, epilessia, schizofrenia: un'insolita associazione 153
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 152
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 152
Fatal R631C mutation is also present in the adult form of CPTII deficiency 151
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population 151
Involvement of miR-126 in autoimmune disorders 150
Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. 150
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 149
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 149
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 149
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 148
Severe rhabdomyolysis in a patient with “Heat Stroke” 148
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 148
A robust tool to quantify disability in patients affected by facio-scapulo-humeral muscular dystrophy. 147
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 147
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 145
Endocrine myopathies: Clinical and histopathological features of the major forms 145
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 145
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 145
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease 144
Juvenile limb-girdle myasthenia gravis 143
MuSK-Associated Myasthenia Gravis: Clinical Features and Management 143
An unusual association of dominant optic atrophy with OPA1 mutations and parkinsonian syndrome. 142
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 142
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach 141
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 141
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 141
Rituximab in AChR subtype of myasthenia gravis: systematic review 141
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 140
Cardiovascular autonomic control in myotonic dystrophy type 1: a correlative study with clinical and genetic data. 140
Clinical, morphological and genetic features of a large cohort of late onset GSDII patients: typical and atypical presentation 140
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 139
Tetraplegia flaccida dopo prolungata infusione di cisatracurio 139
Calpain 3 deficiency in Quail Eater's disease 139
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 139
Amyloid myopathy presenting with rhabdomyolysis 137
Chanarin-Dorfman disease (CDD): clinical, genetic and neuroradiological aspects in an adult case followed over 25 years 137
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 136
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 136
LOCALIZATION OF VINCULIN AND TALIN AT PERINEURIAL CELLS OF HUMAN SURAL NERVE 135
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 134
Amyloid myopathy presenting with rhabdomyolysis. 133
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 133
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 133
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 132
Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy 132
Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series 132
Expression of the trascription factor NFkB in different muscular dystrophies 131
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 129
Autoimmune polyglandular disease (APECED) and mutineuropathy: a case report 129
Malattia di Chanarin-Dorfman: aspetti clinici, gemetici e neuroradiologici di un caso adulto seguito per 25 anni 128
Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects 127
Totale 15.941
Categoria #
all - tutte 111.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/20221.656 13 215 20 71 82 23 169 76 35 174 207 571
2022/20234.254 343 361 182 298 343 428 42 262 1.818 19 120 38
2023/20241.025 97 174 70 86 78 208 34 46 2 82 31 117
2024/20255.383 88 41 77 312 219 148 138 1.113 1.330 345 560 1.012
2025/202615.724 809 1.124 1.251 1.077 1.246 3.340 1.930 1.874 1.846 710 307 210
Totale 32.747